United States - Re-Export of Insulin Not in Dosage Forms
Since 2014, United States Re-Export of Insulin Not in Dosage Forms jumped by 218.3% year on year. With $4,155,438 in 2019, the country was number 1 comparing other countries in Re-Export of Insulin Not in Dosage Forms. Jordan, United Arab Emirates and New Zealand respectively ranked number 2, 3 and 4 in this ranking.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 4,155,438.00 |
| 2018 | 5,366,183.00 |
| 2017 | 304,925.00 |
| 2016 | 30,405.00 |
| 2015 | 192,557.00 |
Download all data from 1993 to 2019
How does United States rank in Re-Export of Insulin Not in Dosage Forms?
| # | 4 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
4,155,438.00 | 2019 | -22.6 % | +218.3 % | View data |
| 2 |
#2
Jordan
|
14,085.00 | 2016 | NA | NA | View data |
| 3 |
#3
United Arab Emirates
|
544.59 | 2017 | -100.0 % | NA | View data |
| 4 |
#4
New Zealand
|
30.87 | 2015 | NA | NA | View data |